Pfizer launches new biopharmaceutical company to develop Parkinson’s drugs

News

Author: Simge Eva DoganPublished: 7 November 2018

Prep: Cook: Serves:

Pharmaceutical company Pfizer has teamed with investment firm Bain Capital to launch Cerevel Therapeutics – a biopharmaceutical company focused on developing drugs for Parkinson’s and other central nervous system conditions.

The new company – which will receive US $350 million of investment from Bain Capital – will begin working on phase three clinical trials on a Parkinson’s drug designed to increase levels of dopamine in the brain. Cerevel will also continue to develop several of Pfizer’s drug programmes which closed earlier this year.

Marco Baptista, director of research programmes at The Michael J Fox Foundation – which has partnered with Pfizer since 2010 – said: “This is welcome news for Parkinson’s patients and researchers. Pfizer had developed a diverse group of novel therapeutics for Parkinson’s disease, which are now going to get another chance at success. MJFF looks forward to partnering with Cerevel to support the advancement of these promising programs.”

To read more on this topic click here.

For more information on Parkinson’s treatments please visit the EPDA website

New smart glasses could track Parkinson’s symptoms

Last Month

Next Month

Go Back

Share this story

Comments

In my country

Why I launched Nepal’s first Parkinson’s support group

Overcoming tough economic challenges in Nepal

Meet EPDA vice-president Susanna Lindvall as she gets involved in #UniteForParkinsons 2018

International Women's Day interview special

“It’s so rewarding to help people improve their communication”

Find out about a new voice therapy app for Parkinson’s disease

Regular exercise may slow progression of early Parkinson’s disease symptoms

A research team in Japan has suggested that around four hours of weekly moderate exercise is associated with a better clinical course of early-stage Parkinson’s. Their study, published in ‘Neurology’, drew on data from 237 people with the condition, whose symptoms were monitored over a period of up to six years. The research showed that people who were regularly active for at least one to two hours, one or two days a week, were better able to maintain daily activities than those who exercised less – and even experienced a “slower deterioration of processing speed”. The researchers highlighted that these benefits stemmed from maintaining regular exercise over time, rather than levels of activity at the onset of the condition. They added that their findings “suggest it may never be too late for someone with Parkinson’s to start an exercise programme”.

Could traumatic brain injury accelerate the onset of Parkinson’s disease?

Undergoing a traumatic brain injury (TBI) – a sudden injury that damages the brain – may be linked to Parkinson’s onset at an earlier age, new research suggests. The study, led by researchers in the US, examined data from the National Alzheimer’s Coordinating Centre (NACC) database and assessed whether TBI was associated with age of disease onset, survival and the degeneration of dopamine-producing nerve cells in the brain. They found that while there was no significant association with age of death or greater impact on dopamine-producing nerve cells, results showed that TBI was linked to a 4.9-year earlier age of Parkinson’s onset. Reflecting on the results, the researchers wrote that traumatic brain injury “appears to accelerate Parkinson’s onset without altering age of death”. However, the researchers also cautioned that “the nature of this relationship remains unclear”.

NASA astronaut who lived with Parkinson’s disease has died

“When I got diagnosed with Parkinson’s I thought it was over,” US astronaut Michael “Rich” Clifford once said, in a webcast conversation with Parkinson’s expert Dr Ray Dorsey. But when US space agency NASA offered him another opportunity to board a space shuttle, despite the onset of Parkinson’s symptoms, he didn’t hesitate. “And it was as easy as that.” Now, nearly 30 years since his final venture into space, Clifford has died due to complications from Parkinson’s disease. He leaves a legacy of three journeys into space, several awards for his services to the space programme – including the NASA Space Flight Medal – and a history of advocacy for people with Parkinson’s. In a 2013 conversation with the Michael J Fox Foundation, Clifford said: “Everyone with Parkinson’s handles it differently. Don’t let it get in the way of living. “Life is too good. Keep going. The sky’s the limit.” Image credit:…

All fields required

First name*
Last name*
Email address*
Enter Email Confirm Email
Country of residence*
About me*
- I have Parkinson's disease
- I am a partner / carer / family / friend of someone who has Parkinson's
- I am a healthcare professional with an interest in Parkinson's
- I work for a Parkinson's disease organisation
- Other
CAPTCHA
*
- By proceeding you agree to our
Phone
This field is for validation purposes and should be left unchanged.

Pfizer launches new biopharmaceutical company to develop Parkinson’s drugs

News

Author: Simge Eva DoganPublished: 7 November 2018

Prep: Cook: Serves:

Last Month

Next Month

Share this story

Comments

In my country

Why I launched Nepal’s first Parkinson’s support group

Interviews

Meet EPDA vice-president Susanna Lindvall as she gets involved in #UniteForParkinsons 2018

Interviews

“It’s so rewarding to help people improve their communication”

Regular exercise may slow progression of early Parkinson’s disease symptoms

Could traumatic brain injury accelerate the onset of Parkinson’s disease?

NASA astronaut who lived with Parkinson’s disease has died

{title}

Subscribe

Pfizer launches new biopharmaceutical company to develop Parkinson’s drugs

News

Author: Simge Eva DoganPublished: 7 November 2018

Last Month

Next Month

Share this story

Comments

Related articles

In my country

Why I launched Nepal’s first Parkinson’s support group

Interviews

Meet EPDA vice-president Susanna Lindvall as she gets involved in #UniteForParkinsons 2018

Interviews

“It’s so rewarding to help people improve their communication”

Regular exercise may slow progression of early Parkinson’s disease symptoms

Could traumatic brain injury accelerate the onset of Parkinson’s disease?

NASA astronaut who lived with Parkinson’s disease has died

{title}

Subscribe

Sign in